tiprankstipranks
Trending News
More News >
Perfect Medical Health Management Limited (HK:1830)
:1830
Hong Kong Market
Advertisement

Perfect Medical Health Management Limited (1830) AI Stock Analysis

Compare
11 Followers

Top Page

HK:1830

Perfect Medical Health Management Limited

(1830)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 4o)
Rating:66Neutral
Price Target:
HK$1.50
▲(6.38% Upside)
The stock's overall score is driven primarily by its strong valuation, offering a low P/E ratio and high dividend yield. However, the financial performance is hindered by declining revenue and cash flow growth, and technical indicators suggest a bearish trend. The absence of earnings call data and notable corporate events limits additional insights.

Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)

Perfect Medical Health Management Limited Business Overview & Revenue Model

Company DescriptionPerfect Medical Health Management Limited, an investment holding company, provides medical and aesthetic medical services in Hong Kong, China, Macau, Singapore, and Australia. It offers medical beauty, hair growth, pain management, preventive care, and fertility care services. The company also provides advertising, charitable, and management services; holds trademarks; and rents equipment. In addition, it operates service centers. The company was formerly known as Perfect Shape Medical Limited and changed its name to Perfect Medical Health Management Limited in June 2021. Perfect Medical Health Management Limited was founded in 2003 and is headquartered in Mong Kok, Hong Kong.
How the Company Makes MoneyThe company generates revenue through multiple streams, including subscription fees from healthcare providers for access to its telemedicine platform, consulting fees for health data analytics services, and fees from personalized health program implementations. In addition, Perfect Medical Health Management Limited has established strategic partnerships with hospitals and insurance companies, allowing it to offer bundled services and gain a share of the revenue from the healthcare transactions facilitated through its platform. These partnerships enhance its credibility and expand its customer base, contributing significantly to its earnings.

Perfect Medical Health Management Limited Financial Statement Overview

Summary
The company demonstrates strong profitability with healthy profit margins and a stable balance sheet. However, it faces challenges in revenue and free cash flow growth, which highlights potential areas for improvement in sustaining growth momentum.
Income Statement
65
Positive
The company has experienced a decline in revenue growth, with a notable decrease of 12.94% in the latest year. However, it maintains healthy profitability margins, with a gross profit margin of 63.77% and a net profit margin of 18.34%. The EBIT and EBITDA margins are also strong at 23.37% and 39.19%, respectively. Despite the revenue decline, the company demonstrates solid profitability.
Balance Sheet
70
Positive
The balance sheet shows a moderate debt-to-equity ratio of 0.57, indicating a balanced leverage position. The return on equity is robust at 54.45%, reflecting efficient use of equity to generate profits. The equity ratio stands at 40.59%, suggesting a stable financial structure with adequate equity backing.
Cash Flow
60
Neutral
The company has faced a decline in free cash flow growth, down by 16.77% in the latest year. However, the operating cash flow to net income ratio is strong at 0.83, and the free cash flow to net income ratio is 0.90, indicating effective cash generation relative to net income. Despite the decline in free cash flow growth, the company maintains a solid cash flow position.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.30B1.13B1.39B1.39B1.35B1.09B
Gross Profit819.54M719.22M911.37M662.60M689.93M553.44M
EBITDA405.50M441.97M596.91M592.40M602.84M474.13M
Net Income290.25M206.90M315.80M315.64M305.25M284.63M
Balance Sheet
Total Assets1.08B935.91M1.22B1.30B1.28B1.48B
Cash, Cash Equivalents and Short-Term Investments471.42M386.80M567.40M656.85M454.37M532.89M
Total Debt238.70M216.65M268.73M240.35M311.07M261.60M
Total Liabilities634.89M557.18M725.00M684.02M786.93M795.52M
Stockholders Equity452.19M379.95M497.51M612.27M494.27M684.85M
Cash Flow
Free Cash Flow358.30M298.23M445.50M533.81M372.16M527.69M
Operating Cash Flow412.48M332.88M497.12M560.55M516.71M605.91M
Investing Cash Flow-235.97M-171.93M162.56M-222.51M8.05M-300.82M
Financing Cash Flow-517.69M-477.95M-520.97M-335.02M-565.97M-394.41M

Perfect Medical Health Management Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.41
Price Trends
50DMA
1.50
Negative
100DMA
1.64
Negative
200DMA
1.88
Negative
Market Momentum
MACD
-0.02
Negative
RSI
43.83
Neutral
STOCH
30.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Negative. The current price of 1.41 is below the 20-day moving average (MA) of 1.43, below the 50-day MA of 1.50, and below the 200-day MA of 1.88, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 43.83 is Neutral, neither overbought nor oversold. The STOCH value of 30.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1830.

Perfect Medical Health Management Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$612.50M7.3125.63%6.04%-1.62%-10.07%
69
Neutral
HK$1.84B39.1654.98%45.40%12.38%
66
Neutral
HK$1.80B8.6847.16%11.60%-19.05%-34.49%
59
Neutral
HK$368.00M34.727.45%-18.43%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
46
Neutral
HK$63.31M-2.50%-0.31%47.17%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1830
Perfect Medical Health Management Limited
1.40
-1.01
-41.91%
HK:1161
Water Oasis Group
0.91
0.11
14.47%
HK:0919
Modern Healthcare Technology Holdings Limited
0.07
-0.02
-23.40%
HK:1827
Miricor Enterprises Holdings Ltd
0.92
-0.18
-16.36%
HK:8603
Fameglow Holdings Limited
2.10
1.46
228.13%

Perfect Medical Health Management Limited Corporate Events

Perfect Medical Health Management Limited Announces AGM Results
Aug 8, 2025

Perfect Medical Health Management Limited announced the results of its Annual General Meeting held on August 8, 2025. All proposed resolutions, including the adoption of financial statements, approval of a final dividend, re-election of directors, and re-appointment of auditors, were passed with overwhelming support. The approval of mandates for issuing and repurchasing shares indicates the company’s strategic flexibility in managing its capital structure, which could impact its market positioning and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 17, 2025